Francesca Miotto
Counsel
Brussels
Francesca Miotto
Counsel
Brussels
Contact Details
Francesca is Counsel in the antitrust team in Brussels and is a member of the firm’s life sciences group. Francesca has 13 years’ experience in providing strategic counsel on all aspects of EU competition law in a diverse range of sectors. She has particular experience in advising on complex multi-jurisdictional merger reviews and on some of the most complex investigations by the European Commission (EC) in recent years, including on abuse of dominance issues and cartel settlement procedures. In recent years, Francesca has developed a depth of experience in advising on private enforcement across the EU and beyond.
Francesca has also represented clients in appeal proceedings before the European courts in several high-profile cases.
Francesca regularly publishes and speaks on competition law, private enforcement and life sciences topics. She is qualified in the UK and Belgium and has spent time working in both the London and Brussels antitrust teams, as well as in our Paris office.
Francesca is bilingual in English and Italian and also fluent in French, with a good command of Spanish.
Expertise
Practices
Sectors
Office
Brussels
Allen & Overy (Belgium) LLP
Tervurenlaan 268A avenue de Tervueren
Brussels
1150
Qualifications
Professional
Admitted as solicitor, England and Wales, 2007
Admitted as “avocate” (Brussels, Belgium), 2019
Academic
GDL, Economics for Competition Law, King's College London
GDL, Competition Law, King's College London
PLC (Distinction), BPP Law School, London
LLB (Hons), Law, City University London
MA (Hons), Modern Languages, Christ Church, Oxford University
Expertise
Practices
Sectors
Office
Brussels
Allen & Overy (Belgium) LLP
Tervurenlaan 268A avenue de Tervueren
Brussels
1150
Qualifications
Professional
Admitted as solicitor, England and Wales, 2007
Admitted as “avocate” (Brussels, Belgium), 2019
Academic
GDL, Economics for Competition Law, King's College London
GDL, Competition Law, King's College London
PLC (Distinction), BPP Law School, London
LLB (Hons), Law, City University London
MA (Hons), Modern Languages, Christ Church, Oxford University
Experience highlights
Advising Scania in the EC’s trucks cartel investigation and related private damages claims, as well as in appeal proceedings before the General Court of the EU.
Advising Major global banks in confidential and parallel antitrust investigations by various competition authorities, including the EC.
Advising Huntsman in the Phase II merger control review by the EC of its acquisition of Rockwood.
Advising Nynas in the Phase II merger control review by the EC of its acquisition of the Harburg refinery from Shell.
Recognition
An “impressive follow-on damages expert” who provides “strong insights into the Commission’s thinking and likely reactions.”
Who's Who Legal Competition - Future Leader, 2019
News & insights
Publications: 02 APRIL 2020
Covid-19 coronavirus and the EU State aid response
The European Commission (Commission) has adopted a temporary framework for State aid measures to support the economy in the Covid-19 coronavirus outbreak (the Temporary Framework).
Read more
Publications: 02 APRIL 2020
On 24 March 2020, the Government of Vietnam promulgated Decree No. 35/2020/ND-CP setting forth, among other things, the long-awaited notification thresholds of the new Vietnamese merger control regime set out in the 2018 Competition Law (Decree 35).
Read more
Publications: 10 FEBRUARY 2020
EU’s top court clarifies when a patent settlement agreement can infringe EU antitrust rules
The Court of Justice of the EU (ECJ) has for the first time ruled on the issue of settlement agreements involving a value transfer (monetary or otherwise) between the holder of a pharmaceutical patent and generic drug manufacturers (so-called ‘pay-for-delay’ agreements). It has clarified the criteria governing when entry into this type of agreement can breach EU antitrust rules either on the basis that it amounts to an anti-competitive agreement or constitutes an abuse of dominance by the manufacturer of the originator medicine (the originator).
Read more
Publications: 24 OCTOBER 2019
An examination of global class action regimes after Godfrey
On September 20, 2019, the Supreme Court of Canada (“SCC”) issued a landmark antitrust class action decision in Pioneer Corp. v Godfrey which clarified several procedural questions relating to class actions.
Read more